Investor presentation
Logotype for Graham Corporation

Graham (GHM) Investor presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for Graham Corporation

Investor presentation summary

18 Aug, 2026

Business overview and market positioning

  • Provides mission-critical engineered products for defense, space, energy, and process industries, serving over 100 countries with 8 global locations and 730+ employees.

  • Portfolio diversified across defense (60% FY26 revenue), energy & process (34%), and space (6%), with strong synergies and cross-market opportunities.

  • Defense segment benefits from long-term U.S. Navy programs, high barriers to entry, and recurring revenue from installed base; space and energy segments leverage proprietary technologies and global demand.

  • Materials processing business adds recurring revenue through consumables and services, with $30M revenue expected in FY27.

Growth strategy and operational excellence

  • Strategic plan follows a phased approach: stabilize, improve, and growth, with FY23-25 focused on stabilization and FY26-27 on improvement.

  • Completed major facility investments, including new Navy and cryogenic test facilities, to expand capacity and reduce lead times.

  • Growth driven by product lifecycle investments, R&D, global expansion (notably in India), and proactive aftermarket acceleration.

  • Disciplined M&A strategy targets engineered product companies with strong IP, aiming for 8-10% annual organic growth supplemented by acquisitions every 12-18 months.

Financial performance and outlook

  • Q1 FY27 sales rose 29% YoY to $71.3M, with strong growth in space (+86%), defense (+40%), and aftermarket (+20%).

  • Gross profit increased 21% YoY in Q1 FY27, though gross margin declined to 25% due to a higher mix of lower-margin defense sales.

  • Adjusted EBITDA margin reached 12.3% in Q1 FY27; annual guidance for FY27 targets $285-295M net sales, 24.5-25.5% gross margin, and 13% adjusted EBITDA margin.

  • Record backlog of $557M, with 35-40% expected to convert to sales in the next 12 months; book-to-bill ratio at 1.3x.

  • Balance sheet strengthened by $50M PIPE financing, zero debt, and $27M cash; capex and R&D investments support future growth.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more